Cargando…
Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer
Development of solid cancer depends on escape from host immunosurveillance. Various types of immune cells contribute to tumor-induced immune suppression, including tumor associated macrophages, regulatory T cells, type 2 NKT cells, and myeloid-derived suppressor cells (MDSCs). Growing body of eviden...
Autores principales: | Katoh, Hiroshi, Watanabe, Masahiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452485/ https://www.ncbi.nlm.nih.gov/pubmed/26078490 http://dx.doi.org/10.1155/2015/159269 |
Ejemplares similares
-
Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
por: Law, Andrew M. K., et al.
Publicado: (2020) -
Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more
por: Shibata, Masahiko, et al.
Publicado: (2022) -
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
por: Li, Kai, et al.
Publicado: (2021) -
Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer
por: Wesolowski, Robert, et al.
Publicado: (2013) -
Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches
por: Thyagarajan, Anita, et al.
Publicado: (2019)